Global X Genomics & Biotechnology ETF (GNOM) Holdings List $46.54 0.00 (0.00%) As of 05/22/2026 03:59 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock What stocks does GNOM hold? The Global X Genomics & Biotechnology ETF (GNOM) top stock holdings include Illumina, Guardant Health, and Legend Biotech. The top 25 GNOM holdings ordered by weight make up 82.40% of the total fund. GNOM is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete GNOM stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure. Top 25 GNOM HoldingsRankCompanyCurrent PriceWeightShares Held1ILMNIllumina$144.414.71%16,5122GHGuardant Health$118.954.64%24,0593LEGNLegend Biotech$29.374.52%83,0994ARWRArrowhead Pharmaceuticals$74.954.34%29,1505VRTXVertex Pharmaceuticals$434.524.33%4,9236PRAXPraxis Precision Medicines$343.564.13%6,3887NTRANatera$203.194.02%10,3708BMRNBioMarin Pharmaceutical$54.093.98%39,7929MRNAModerna$46.883.76%38,75510CRSPCRISPR Therapeutics$50.363.74%38,191 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11QGENQiagen$35.23+0.2%3.67%53,90912VCYTVeracyte$45.033.66%43,80713BNTXBioNTech$92.143.55%19,84114TWSTTwist Bioscience$60.573.32%33,08715TECHBio-Techne$48.213.29%36,78316BEAMBeam Therapeutics$28.642.83%52,30617TXG10x Genomics$23.682.75%63,66518RAREUltragenyx Pharmaceutical$23.392.56%52,42619LLYEli Lilly and Company$1,066.59+0.1%2.33%1,16920Genscript Biotech CorporationN/A2.21%638,81821GILDGilead Sciences$134.362.12%8,10722CAICaris Life Sciences$15.552.06%67,74823AstraZeneca PLCN/A2.03%5,49024BLLNBilliontoone$85.921.93%11,12125SRPTSarepta Therapeutics$16.801.92%56,133 GNOM Geographic ExposureGNOM's largest geographic exposure is United States at 81.9%, followed by Switzerland at 3.7%.United States81.9%Switzerland3.7%Cayman Islands2.0%United Kingdom2.0%Singapore1.1%GNOM Currency ExposureGNOM's largest currency exposure is USD at 76.8%, followed by HKD at 2.0%.USD76.8%HKD2.0%GBP2.0%GNOM Sector ExposureGNOM's largest sector exposure is Health Care at 84.6%, followed by Consumer Discretionary at 5.5%.Health Care84.6%Consumer Discretionary5.5%Energy0.6%Industrials0.3%GNOM Industry ExposureGNOM's largest industry exposure is Biotechnology at 55.8%, followed by Health Care Equipment & Supplies at 15.7%.Biotechnology55.8%Health Care Equipment & Supplies15.7%Life Sciences Tools & Services6.0%Health Care Providers & Services6.0%Diversified Consumer Services5.5%Pharmaceuticals1.1%Renewable Energy0.6%Electrical Equipment0.3%GNOM Sub-Industry ExposureGNOM's largest sub-industry exposure is Biotechnology at 55.8%, followed by Life Sciences Tools & Services at 20.6%.Biotechnology55.8%Life Sciences Tools & Services20.6%Health Care Services6.0%Pharmaceuticals1.1%Health Care Equipment1.1%Renewable Energy Equipment0.6%Electrical Components & Equipment0.3% Related Companies and Tools Related Companies HRTS Holdings THMZ Holdings OZEM Holdings CEFA Holdings EQRR Holdings BOTT Holdings CCSO Holdings FMET Holdings TCHI Holdings CARZ Holdings This page (NASDAQ:GNOM) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
